We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+0.76%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$13.6B
AUM Growth
+$1.31B
(+11%)
Cap. Flow
+$1.24B
Cap. Flow
% of AUM
9.18%
Top 10 Holdings %
Top 10 Hldgs %
52.17%
Holding
753
New
79
Increased
425
Reduced
211
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$190M |
| 2 |
Enterprise Products Partners
EPD
|
+$96.4M |
| 3 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$94.8M |
| 4 |
Plains All American Pipeline
PAA
|
+$81.9M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$76.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nucor
NUE
|
+$36.6M |
| 2 |
NOV
NOV
|
+$34.2M |
| 3 |
Qualcomm
QCOM
|
+$34.1M |
| 4 |
CenterPoint Energy
CNP
|
+$32.7M |
| 5 |
ConocoPhillips
COP
|
+$31.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 67.49% |
| 2 | Financials | 2.86% |
| 3 | Materials | 2.35% |
| 4 | Healthcare | 2.33% |
| 5 | Industrials | 1.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Neurocrine Biosciences
NBIX
$17.7B
| $3.23M | 0.02% |
83,482
-27,113
| -25% | -$1.23M |
|
152
Public Storage
PSA
$60.2B
| $3.2M | 0.02% |
14,304
-1,792
| -11% | -$381K |
|
153
Archrock
AROC
$6.33B
| $3.12M | 0.02% |
236,016
+151,064
| +178% | +$1.95M |
|
154
Simon Property Group
SPG
$74.5B
| $3.09M | 0.02% |
17,384
-162
| -0.9% | -$30.1K |
|
155
Alnylam Pharmaceuticals
ALNY
$36.3B
| $3.09M | 0.02% |
+82,468
| New | +$3.45M |
|
156
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17B
| $3.01M | 0.02% |
29,672
-5,693
| -16% | -$577K |
|
|
ENLC
157
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $2.98M | 0.02% |
156,671
+98,042
| +167% | +$1.68M |
|
|
AKRX
158
DELISTED
Akorn Inc
AKRX
| $2.96M | 0.02% |
135,510
-40,170
| -23% | -$924K |
|
|
EXK
159
Endeavour Silver
EXK
$2.32B
| $2.91M | 0.02% |
825,739
-150,188
| -15% | -$606K |
|
|
LKFT
160
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
| $2.84M | 0.02% |
44,309
-14,473
| -25% | -$891K |
|
161
Ultragenyx Pharmaceutical
RARE
$2.65B
| $2.76M | 0.02% |
39,264
-11,010
| -22% | -$781K |
|
162
OGE Energy
OGE
$10.3B
| $2.72M | 0.02% |
81,365
-16,240
| -17% | -$513K |
|
163
Prologis
PLD
$138B
| $2.66M | 0.02% |
50,379
-5,835
| -10% | -$297K |
|
|
GWPH
164
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $2.65M | 0.02% |
+23,742
| New | +$2.86M |
|
|
ICPT
165
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.59M | 0.02% |
23,842
-7,679
| -24% | -$915K |
|
166
Sibanye-Stillwater
SBSW
$5.92B
| $2.56M | 0.02% |
385,179
+66,129
| +21% | +$603K |
|
|
GAU
167
Galiano Gold
GAU
$486M
| $2.56M | 0.02% |
836,046
-182,705
| -18% | -$631K |
|
|
HZNP
168
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.51M | 0.02% |
154,966
-50,163
| -24% | -$910K |
|
|
SAND
169
DELISTED
Sandstorm Gold
SAND
| $2.45M | 0.02% |
627,837
-11,289
| -2% | -$47.3K |
|
170
Equinix
EQIX
$107B
| $2.42M | 0.02% |
6,785
-644
| -9% | -$225K |
|
171
AvalonBay Communities
AVB
$27.1B
| $2.32M | 0.02% |
13,114
-1,607
| -11% | -$271K |
|
172
Harmony Gold Mining
HMY
$9.92B
| $2.3M | 0.02% |
1,039,691
+76,452
| +8% | +$203K |
|
173
Welltower
WELL
$178B
| $2.29M | 0.02% |
34,193
-4,038
| -11% | -$267K |
|
174
Equity Residential
EQR
$25.4B
| $2.25M | 0.02% |
34,931
-4,186
| -11% | -$257K |
|
|
BLUE
175
DELISTED
bluebird bio
BLUE
| $2.21M | 0.02% |
2,768
-890
| -24% | -$707K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q4 2016 Portfolio in Review
As of Q4 2016, ALPS Advisors held 753 positions worth $13.6B, up 11% from $12.3B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
ALPS Advisors deployed $1.24B of net new capital in Q4 2016, opening 79 new positions and adding to 425 existing holdings. Its largest new stake was Eli Lilly: 558,209 shares worth $41.1M.
By sector, the portfolio is most concentrated in Energy at 67% of assets, up from 66% a quarter earlier, followed by Financials and Materials.
On the sell side, the largest reduction was Nucor, an estimated $36.6M trimmed.
- ALPS Advisors's largest Q4 2016 buy was Eli Lilly: 558,209 shares worth $41.1M.
- ALPS Advisors added most to Energy Transfer Partners L.p. in Q4 2016, an estimated $190M increase.
- ALPS Advisors's biggest Q4 2016 reduction was Nucor, cutting an estimated $36.6M.
- ALPS Advisors fully exited NOV in Q4 2016, selling an estimated $34.2M.
- ALPS Advisors's ten largest holdings make up 52% of its $13.6B portfolio in Q4 2016.
- ALPS Advisors opened 79 new positions and closed 38 in Q4 2016.
- ALPS Advisors's portfolio value rose 11% quarter-over-quarter to $13.6B.
Based on ALPS Advisors's 13F filing for Q4 2016, filed 24 Jan 2017.